Observational Study Examining Kidney Transplantation Outcomes Following Donation From Individuals That Died of Drug Toxicity in British Columbia, Canada
Authors:
Open Access
- 1 January 2023
- journal article
- research article
- Published by SAGE Publications in Canadian Journal of Kidney Health and Disease
- Vol. 10
Abstract
Background: The illicit drug toxicity (overdose) crisis has worsened across Canada, between 2016 and 2021 more than 28 000 individuals have died of drug toxicity. Organ donation from persons who experience drug toxicity death has increased in recent years. Objective: This study examines whether graft loss after kidney transplantation differed by donor cause of death. Design: Retrospective cohort. Setting: Provincial transplant program of British Columbia, Canada. Patients: Transplant recipients who received kidney transplantation from deceased donors aged 12 to 70 years between 2013 and 2019 (N = 1012). Measurements: Transplant recipient all cause graft loss (graft loss due to any cause including death) was compared by donor cause of death from drug toxicity or other. Methods: Five-year Kaplan-Meier estimates of all-cause graft survival, and 3-year complete as well as stratified inverse probability of treatment weighted Cox proportional hazards models were conducted. Results: Drug toxicity death donors donated to 25% (252/1012) of kidney transplantations. Drug toxicity death donors were more likely to be young, white, males, with fewer comorbidities such as diabetes or hypertension but were more likely to have a terminal serum creatinine ≥1.5 mg/dL or be hepatitis C virus (HCV) positive. Unadjusted 5-year estimate of all-cause graft survival was 97% for recipients of drug toxicity donor kidneys and 83% for recipients of non-drug toxicity donor kidneys ( P < .001). Recipients of drug toxicity death donor kidneys had decreased risk of all cause graft loss compared to recipients of non-drug toxicity death donor kidneys (hazard ratio [HR]: 0.30, 95% confidence interval [CI]: 0.12-0.77, P = .012). This is primarily due to the reduced risk of all-cause graft loss for recipients of younger (≤35 years) drug toxicity death donor kidneys (HR: 0.05, 95% CI: 0.00-0.55, P = .015). Limitations: Potential selection bias, potential unmeasured confounding. Conclusions: Donation after drug toxicity death is safe and should be considered more broadly to increase deceased donor kidney donation.Keywords
Funding Information
- Transplant Research Foundation of British Columbia
This publication has 15 references indexed in Scilit:
- Effect of the Opioid Crisis on the Donor Pool for Kidney Transplantation: An Analysis of National Kidney Deceased Donor Trends from 2010–2016American Journal of Nephrology, 2018
- Turn down for what? Patient outcomes associated with declining increased infectious risk kidneysAmerican Journal of Transplantation, 2017
- The “PHS Increased Risk” Label Is Associated With Nonutilization of Hundreds of Organs per YearTransplantation, 2017
- Trial of Transplantation of HCV-Infected Kidneys into Uninfected RecipientsNew England Journal of Medicine, 2017
- Improving Organ Utilization to Help Overcome the Tragedies of the Opioid EpidemicAmerican Journal of Transplantation, 2016
- Estimation of Potential Deceased Organ Donors in CanadaTransplantation, 2016
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studiesStatistics in Medicine, 2015
- Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant OutcomesAmerican Journal of Transplantation, 2011
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- Centers for Disease Control ‘High-Risk’ Donors and Kidney UtilizationAmerican Journal of Transplantation, 2010